October 7, 2020
UNC toxicologist Phillip Clapp, PhD, and retired nurse leader Ernest Grant, PhD, were featured in this well-sourced AP/Frontline documentary on medical supply issues during the COVID-19 pandemic.
October 7, 2020
Ernest Grant, RN, PhD, FAAN president of American Nurses Association and an African American, shares why he is participating in COVID-19 vaccine trial at UNC-Chapel Hill.
October 7, 2020
UNC LMSA Chapter will host Dr. Pablo Serrano, associate professor of abdominal surgery, for a lecture during Hispanic Heritage Month.
October 7, 2020
WUNC Producer Charlie Shelton-Ormond talks with Cindy Gay, MD, the primary investigator of a Phase 3 clinical trial for a COVID vaccine taking place at UNC-Chapel Hill.
October 7, 2020
UNC School of Medicine student Nakisa Sadeghi co-wrote a commentary published in The Lancet in the titled “The opioid crisis and the 2020 US election: crossroads for a national epidemic.”
October 6, 2020
We are pleased to share updates to the UNC Children’s Heart Center. Our overriding mission continues to focus on providing the best family-centered individualized care through a multidisciplinary team approach.
October 6, 2020
Researchers at Oxford and UNC-Chapel Hill, led by Andrew Moon, MD, MPH, and Sidney Barritt, MD, found increased mortality rates among COVID-19 patients with advanced cirrhosis and alcohol-related liver disease.
October 6, 2020
UNC School of Medicine research led by Nilu Goonetilleke, PhD, reveal how HIV-1-specific immune cells can recognize viral particles that have the capacity to rebound following interruptions to antiretroviral therapy. The findings have implications for new treatment strategies.
October 6, 2020
UNC Health and UNC SOM are partnering with Novant and NHRMC to include an expanded relationship with UNC Health for pediatric specialty services and the UNC School of Medicine
October 6, 2020
Frances Ligler, PhD, was presented the prestigious Simon Ramo Founders Award on October 3 at the National Academy of Engineering’s 2020 Annual Meeting.
October 6, 2020
For the first time, the Robert Wood Johnson Foundation named two clinical scholars from the same institution to two different health provider teams in the same year: Crystal Wiley Cené, MD, MPH, and Thava Mahadevan, MS.
October 5, 2020
The first investigational agent to be evaluated by ACTIV-2 is LY3819253, an experimental monoclonal antibody treatment made by Lilly Research Laboratories in partnership with AbCellera Biologics.